SCHEMBL31522156

SCHEMBL31522156

COc1cc(C)cc(Oc2ccccc2NC(=O)[C@@H](C)NC(=O)OC(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MTNR1B P49286 1/20 0.42
▸ MAPT P10636 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ LPAR1 Q92633 4/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SUV39H2 Q9H5I1 1/20 0.38
▸ MMP8 P22894 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ ABCB1 P08183 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567123 0.90 MTNR1B (0.54) LMNAL3MBTL1MTNR1BMAPTALDH1A1
SCHEMBL30567097 0.85 L3MBTL1 (0.60) LMNAL3MBTL1MAPTALDH1A1KDM4E
SCHEMBL31522180 0.82 MTNR1B (0.50) LMNAL3MBTL1MTNR1BMAPTALDH1A1
SCHEMBL31522166 0.80 LMNA (0.50) LMNAL3MBTL1MTNR1BMAPTALDH1A1
SCHEMBL25386658 0.77 MTNR1B (0.59) LMNAL3MBTL1MTNR1BMAPTALDH1A1
SCHEMBL25386654 0.77 MTNR1B (0.59) LMNAL3MBTL1MTNR1BMAPTALDH1A1
SCHEMBL8347748 0.76 PGR (0.53) LMNAMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL31522182 0.75 POLB (0.44) LMNAL3MBTL1MTNR1BALDH1A1KDM4E
SCHEMBL31522171 0.74 KDR (0.42) LMNAL3MBTL1MTNR1BMAPTLPAR1
SCHEMBL15020425 0.74 HPGD (0.51) LMNAMAPTALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054318-A1 PCNA INHIBITORS AND USES THEREOF CITY OF HOPE (US) 2025-03-13 — — WO disclosed
Send feedback